Lantern Pharma Inc. · NASDAQ:LTRN

BIOS Advisors GP, LLC reported a 7.40% stake in Lantern Pharma Inc. (Schedule 13D/A)

Event Apr 16, 2026 · Filed Apr 16, 2026

BIOS Advisors GP, LLC reported a 7.40% stake in Lantern Pharma Inc., 834,752 shares, with active intent on Apr 16, 2026. Filed Apr 16, 2026 (Schedule 13D/A).

Stake
7.40%
Shares
834,752
Intent
Active
What changed
Stake changed
Filed together
14 holders

The filing in full

HolderStakeShares
Bios Equity Partners, LP3.70%420,802
Fletcher Aaron G.L.7.40%834,752
BIOS Advisors GP, LLC7.40%834,752
BIOS Capital Management, LP7.40%834,752
Bios Equity Partners II, LP3.70%413,950
BIOS Fund II, LP0.80%88,029
BIOS Fund II NT, LP0.30%38,479
BIOS Fund II QP, LP2.60%287,442
BIOS Fund I, LP2.20%249,037
BIOS Fund I QP, LP1.30%145,672
BP Directors, LP0.20%26,093
Cavu Advisors, LLC7.40%834,752
Cavu Management, LP7.40%834,752
Kreis Leslie W.7.40%834,752

Source

View original at SEC

Related